Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CochLear Ltd. Unsponsored ADR (CHEOY : OTC)

• Company Description    Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia. Number of Employees: 5,500

• Price / Volume Information    Yesterday's Closing Price: $47.40 Daily Weekly Monthly 20 Day Moving Average: 23,859 shares Shares Outstanding: 130.80 (millions) Market Capitalization: $6,199.82 (millions) Beta: 0.73 52 Week High: $98.49 52 Week Low: $31.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.29% -1.98% 12 Week 15.98% 11.48% Year To Date -45.16% -50.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1 UNIVERSITY AVENUE MACQUARIE UNIVERSITY - SYDNEY,C3 2109 AUS ph: 61-2-9428-6555 fax: - None http://www.cochlear.com

• General Corporate Information    Officers Dig Howitt - Chief Executive Officer and President Alison Deans - Chairman Stuart Sayers - Chief Financial Officer Michael del Prado - Director Christine McLoughlin - Director Peer Information CochLear Ltd. Unsponsored ADR (CHCR) CochLear Ltd. Unsponsored ADR (ESRX) CochLear Ltd. Unsponsored ADR (MYDP) CochLear Ltd. Unsponsored ADR (COR) CochLear Ltd. Unsponsored ADR (GBCS) CochLear Ltd. Unsponsored ADR (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 191459205 SIC: 6770 Fiscal Year Fiscal Year End: June Last Reported Quarter: - Next Expected EPS Date: 11/17/26 Share - Related Items Shares Outstanding: 130.80 Most Recent Split Date: (:1) Beta: 0.73 Market Capitalization: $6,199.82 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 2.91% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $1.38 Current Fiscal Year EPS Consensus Estimate: $1.93 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/17/26

• Fundamental Ratios P/E Current FY Estimate: 24.56 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 5.25 Price/Cash Flow: 21.33 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - - 12/31/25 - - ROA 06/30/26 - - 03/31/26 - - 12/31/25 - - Current Ratio 06/30/26 - 2.15 03/31/26 - - 12/31/25 - 2.46 Quick Ratio 06/30/26 - 1.34 03/31/26 - - 12/31/25 - 1.44 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - 9.11 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - 9.03 03/31/26 - - 12/31/25 - 9.73 Inventory Turnover 06/30/26 - 1.32 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - 0.00 03/31/26 - - 12/31/25 - 0.01 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - - 12/31/25 - 0.74

Powered by Zacks Investment Research ©